$ARRT
Artisan Consumer Goods, Inc.

2022 Q1 Form 10-Q Financial Statement

#000147793222000969 Filed on February 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $3.380K $5.590K $15.12K
YoY Change -62.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $750.00 $750.00 $630.00
YoY Change
% of Gross Profit
Operating Expenses $4.127K $6.342K $15.75K
YoY Change -54.08% 5.44% -182.85%
Operating Profit -$4.127K -$6.342K -$15.75K
YoY Change -54.08% 5.44% -182.85%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $150.00 -$2.686K $2.557K
YoY Change -101.18% -81.2% -90.33%
Pretax Income -$3.980K -$9.030K -$13.19K
YoY Change -81.68%
Income Tax
% Of Pretax Income
Net Earnings -$3.977K -$9.028K -$13.19K
YoY Change -81.7% -55.53% -129.03%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$904.50 -$2.052K -$2.998K
COMMON SHARES
Basic Shares Outstanding 4.400M shares 4.400M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.94K $20.05K $30.20K
YoY Change 591.43%
Cash & Equivalents $16.94K $20.05K $30.20K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $16.94K $20.05K $30.20K
YoY Change 591.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.000K $1.000K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.880K $8.625K $9.375K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $16.94K $20.05K $30.20K
Total Long-Term Assets $7.880K $8.625K $9.375K
Total Assets $24.82K $28.67K $39.57K
YoY Change 913.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.54K $29.51K $34.63K
YoY Change -35.53%
Accrued Expenses $48.25K $48.40K $45.71K
YoY Change -0.43%
Deferred Revenue
YoY Change
Short-Term Debt $154.2K $154.2K $154.2K
YoY Change 50.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $232.0K $232.1K $234.6K
YoY Change 17.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $232.0K $232.1K $234.6K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $232.0K $232.1K $234.6K
YoY Change 17.9%
SHAREHOLDERS EQUITY
Retained Earnings -$19.20M -$19.20M -$19.19M
YoY Change
Common Stock $4.400K $4.400K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$207.2K -$203.5K -$195.0K
YoY Change
Total Liabilities & Shareholders Equity $24.82K $28.67K $39.57K
YoY Change 913.06%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$3.977K -$9.028K -$13.19K
YoY Change -81.7% -55.53% -129.03%
Depreciation, Depletion And Amortization $750.00 $750.00 $630.00
YoY Change
Cash From Operating Activities -$3.110K -$10.14K -$12.43K
YoY Change -76.0% 195.62%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$10.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 $51.72K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.110K -10.14K -$12.43K
Cash From Investing Activities 0.000 0.000 -$10.00K
Cash From Financing Activities 0.000 0.000 $51.72K
Net Change In Cash -3.110K -10.14K $29.29K
YoY Change 5.07% -796.98%
FREE CASH FLOW
Cash From Operating Activities -$3.110K -$10.14K -$12.43K
Capital Expenditures $0.00 $0.00 -$10.00K
Free Cash Flow -$3.110K -$10.14K -$2.425K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4400048 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
560 USD
CY2021Q4 arrt General And Administrative Expenses
GeneralAndAdministrativeExpenses
1389 USD
CY2020Q4 arrt General And Administrative Expenses
GeneralAndAdministrativeExpenses
150 USD
arrt General And Administrative Expenses
GeneralAndAdministrativeExpenses
1556 USD
arrt General And Administrative Expenses
GeneralAndAdministrativeExpenses
45 USD
us-gaap Operating Expenses
OperatingExpenses
22089 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6342 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
12991 USD
CY2021Q4 arrt Other Income Expense
OtherIncomeExpense
-2686 USD
CY2020Q4 arrt Other Income Expense
OtherIncomeExpense
-14286 USD
arrt Other Income Expense
OtherIncomeExpense
-129 USD
arrt Other Income Expense
OtherIncomeExpense
12143 USD
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2686 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14286 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-129 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12143 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-9028 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-20301 USD
us-gaap Net Income Loss
NetIncomeLoss
-22218 USD
us-gaap Net Income Loss
NetIncomeLoss
25134 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7625 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
154216 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
210 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-20301 USD
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4400048 shares
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4400048 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4400048 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4400048 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-152895 USD
CY2020Q4 arrt Common Stock To Be Issued
CommonStockToBeIssued
210 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-172986 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-173040 USD
arrt Common Stock To Be Issued
CommonStockToBeIssued
-25080 USD
us-gaap Net Income Loss
NetIncomeLoss
25134 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-172986 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-194986 USD
CY2021Q4 arrt Common Stock To Be Issued
CommonStockToBeIssued
560 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-9028 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-203454 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-182216 USD
arrt Common Stock To Be Issued
CommonStockToBeIssued
980 USD
us-gaap Net Income Loss
NetIncomeLoss
-22218 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-203454 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1375 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
980 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-25080 USD
arrt Fair Value Adjustment For Shares Issued From Settlement Agreement
FairValueAdjustmentForSharesIssuedFromSettlementAgreement
129 shares
arrt Fair Value Adjustment For Shares Issued From Settlement Agreement
FairValueAdjustmentForSharesIssuedFromSettlementAgreement
-12143 shares
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2840 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3358 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22574 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8731 USD
arrt Asset Purchase Of Within Without Granola
AssetPurchaseOfWithinWithoutGranola
-10000 USD
arrt Asset Purchase Of Within Without Granola
AssetPurchaseOfWithinWithoutGranola
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
51719 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51719 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
19145 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3731 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5409 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20046 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1678 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company provides estimates for its common stock valuations and valuation allowances for deferred taxes.</p>
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
560 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
210 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-25080 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19199107 USD
CY2021Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
750 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1375 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2686 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14286 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-129 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12143 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
154216 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
102497 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001

Files In Submission

Name View Source Status
0001477932-22-000969-index-headers.html Edgar Link pending
0001477932-22-000969-index.html Edgar Link pending
0001477932-22-000969.txt Edgar Link pending
0001477932-22-000969-xbrl.zip Edgar Link pending
arrt-20211231.xsd Edgar Link pending
arrt-20211231_cal.xml Edgar Link unprocessable
arrt-20211231_def.xml Edgar Link unprocessable
arrt-20211231_lab.xml Edgar Link unprocessable
arrt-20211231_pre.xml Edgar Link unprocessable
arrt_10q.htm Edgar Link pending
arrt_10q_htm.xml Edgar Link completed
arrt_ex101.htm Edgar Link pending
arrt_ex101img21.jpg Edgar Link pending
arrt_ex101img22.jpg Edgar Link pending
arrt_ex101img23.jpg Edgar Link pending
arrt_ex101img24.jpg Edgar Link pending
arrt_ex101img25.jpg Edgar Link pending
arrt_ex101img26.jpg Edgar Link pending
arrt_ex101img27.jpg Edgar Link pending
arrt_ex101img28.jpg Edgar Link pending
arrt_ex101img29.jpg Edgar Link pending
arrt_ex101img3.jpg Edgar Link pending
arrt_ex101img30.jpg Edgar Link pending
arrt_ex101img31.jpg Edgar Link pending
arrt_ex101img32.jpg Edgar Link pending
arrt_ex101img33.jpg Edgar Link pending
arrt_ex101img34.jpg Edgar Link pending
arrt_ex101img35.jpg Edgar Link pending
arrt_ex101img36.jpg Edgar Link pending
arrt_ex101img37.jpg Edgar Link pending
arrt_ex101img38.jpg Edgar Link pending
arrt_ex101img39.jpg Edgar Link pending
arrt_ex101img40.jpg Edgar Link pending
arrt_ex101img41.jpg Edgar Link pending
arrt_ex101img42.jpg Edgar Link pending
arrt_ex101img43.jpg Edgar Link pending
arrt_ex101img44.jpg Edgar Link pending
arrt_ex101img45.jpg Edgar Link pending
arrt_ex101img46.jpg Edgar Link pending
arrt_ex101img47.jpg Edgar Link pending
arrt_ex101img48.jpg Edgar Link pending
arrt_ex101img49.jpg Edgar Link pending
arrt_ex101img50.jpg Edgar Link pending
arrt_ex101img51.jpg Edgar Link pending
arrt_ex101img52.jpg Edgar Link pending
arrt_ex101img53.jpg Edgar Link pending
arrt_ex101img7.jpg Edgar Link pending
arrt_ex101img8.jpg Edgar Link pending
arrt_ex101img9.jpg Edgar Link pending
arrt_ex311.htm Edgar Link pending
arrt_ex312.htm Edgar Link pending
arrt_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending